Ara
Toplam kayıt 1, listelenen: 1-1
The CYP 2C19*2 and CYP2C19*17 polymorphisms play a vital role in platelet responsiveness to clopidogrel after percutaneous coronary intervention: a pharmacogenomic study
(Elsevier, 2015)
Background: Clopidogrel inhibits platelet activation and aggregation by blocking the P2Y12 receptor. Dual antiplatelet therapy with
clopidogrel and aspirin is recommended treatment by current guidelines for patients ...